Travelers Companies stock kpis
Want to see TRV full AI Analyst Report?
Gross Written Premiums by Segment
Travelers Companies reported gross written premiums by segment of $12.06B in Q3 2026, down 1.2% from Q2 2026 and down 1.9% year over year. The highest value was $12.29B in Q3 2025.
Reports total premiums written before reinsurance, useful for gauging raw sales and market share in each line and for spotting shifts in underwriting appetite before the impact of reinsurance cessions.
Business Insurance is the clear growth engine—consistent quarter-over-quarter step-ups and record new business show pricing and underwriting are working—while Bond & Specialty is accelerating (surety-driven) and becoming a meaningful contributor. Personal Insurance remains seasonal and lumpier; the recent March dip likely reflects intentional underwriting pullbacks in national property and reinsurance shifts (personal‑lines CAT XOL not renewed), which curbs premium but protects margins. With rising investment income and active buybacks, management is prioritizing disciplined underwriting over volume; watch retained catastrophe exposure for downside volatility.
TRV Gross Written Premiums by Segment
| Period | Business Insurance | Bond & Speciality Insurance | Personal Insurance | Total |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $6.30B | $1.32B | $4.45B | $12.06B |
| Q2 2026Jun 30, 2026 | $6.53B | $1.33B | $4.34B | $12.20B |
| Q1 2026Mar 31, 2026 | $6.79B | $1.21B | $3.75B | $11.75B |
| Q4 2025Dec 31, 2025 | $5.84B | $1.19B | $4.26B | $11.30B |
| Q3 2025Sep 30, 2025 | $6.28B | $1.16B | $4.85B | $12.29B |
| Q2 2025Jun 30, 2025 | $6.36B | $1.17B | $4.70B | $12.22B |
| Q1 2025Mar 31, 2025 | $6.74B | $1.13B | $4.02B | $11.89B |
| Q4 2024Dec 31, 2024 | $5.79B | $1.15B | $4.29B | $11.23B |
| Q3 2024Sep 30, 2024 | $6.17B | $1.17B | $4.81B | $12.15B |
| Q2 2024Jun 30, 2024 | $6.17B | $1.13B | $4.57B | $11.87B |
| Q1 2024Mar 31, 2024 | $6.38B | $1.08B | $3.85B | $11.31B |
| Q4 2023Dec 31, 2023 | $5.39B | $1.06B | $4.00B | $10.46B |
| Q3 2023Sep 30, 2023 | $5.68B | $1.08B | $4.50B | $11.26B |
| Q2 2023Jun 30, 2023 | $5.66B | $1.03B | $4.21B | $10.91B |
| Q1 2023Mar 31, 2023 | $5.83B | $1.01B | $3.51B | $10.35B |
| Q4 2022Dec 31, 2022 | $4.72B | $994.00M | $3.53B | $9.24B |
| Q3 2022Sep 30, 2022 | $4.86B | $1.04B | $3.90B | $9.81B |
| Q2 2022Jun 30, 2022 | $4.79B | $1.04B | $3.71B | $9.54B |
| Q1 2022Mar 31, 2022 | $5.15B | $1.01B | $3.13B | $9.28B |
| Q4 2021Dec 31, 2021 | $4.24B | $988.00M | $3.13B | $8.36B |
| Q3 2021Sep 30, 2021 | $4.45B | $984.00M | $3.44B | $8.88B |
| Q2 2021Jun 30, 2021 | $4.36B | $919.00M | $3.32B | $8.60B |
| Q1 2021Mar 31, 2021 | $4.78B | $834.00M | $2.80B | $8.41B |

